DTaP-poliovirus vaccine paediatric - GlaxoSmithKline

Drug Profile

DTaP-poliovirus vaccine paediatric - GlaxoSmithKline

Alternative Names: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Paediatric) - GlaxoSmithKline; DTaP-IPV paediatric vaccine - GlaxoSmithKline; Infanrix IPV; Infanrix-IPV; Kinrix

Latest Information Update: 21 Apr 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Bacterial vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Diphtheria; Pertussis; Poliomyelitis; Tetanus

Most Recent Events

  • 24 Jun 2008 Registered for Diphtheria in USA (IM)
  • 24 Jun 2008 Registered for Pertussis in USA (IM)
  • 24 Jun 2008 Registered for Poliomyelitis in USA (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top